Last updated: June 4, 2026
OMNIPAQUE 70 suppliers: who manufactures and supplies Omnipaque 70 (iohexol) and its supply chain
Omnipaque 70 (iohexol 300 mg I/mL, 350 mg I/mL in some markets; US “Omnipaque 240/300/350” naming varies by strength) is supplied in the US by GE Healthcare (part of GE HealthCare) and in many markets through local affiliates and wholesalers under the GE HealthCare product portfolio. The practical supplier set for “Omnipaque 70” is therefore the brand holder (GE HealthCare) plus authorized distributor/wholesale channels, while generic and alternative iohexol suppliers depend on the strength and market-specific approvals and procurement.
No further supplier detail can be produced from the information provided, because “OMNIPAQUE 70” is not a standard, unambiguous strength label across jurisdictions and product listings, and supplier identity must be tied to the exact market (country), strength, and NDC/marketing authorization.
Who supplies Omnipaque 70 (iohexol 70) in the US?
Answer: GE HealthCare (brand manufacturer) supplies Omnipaque products in the US through authorized distribution channels.
Which entities appear as drug product suppliers vs distributors?
- Drug product holder/manufacturer (brand): GE HealthCare (GE Healthcare).
- Distribution: wholesalers and distributors are the immediate “suppliers” to hospitals and group purchasing organizations, but they are not the product developer or marketing authorization holder.
What other companies supply iohexol contrast media besides GE Healthcare?
Answer: In most markets, the supply base includes GE HealthCare plus other iohexol manufacturers and private-label distributors; the set depends on exact strength and country.
How “Omnipaque” naming maps to iohexol strengths
“Omnipaque” is marketed as iohexol across multiple iodine concentrations (commonly 240, 300, 350 mg I/mL depending on country). A “70” label is typically either:
- a local shorthand for iodine concentration or vial specification, or
- a different packaging convention, not the standard “240/300/350” naming used in many regulatory filings.
Because supply depends on the exact approved formulation and strength, generic/alternative supplier lists must be strength- and country-specific.
Is there a generic or alternative supplier for Omnipaque 70?
Answer: Alternative iohexol products exist in many markets, but whether a “generic Omnipaque 70” exists depends on local regulatory approvals and whether the strength matches the approved generic entry points.
Procurement impact
- If the procurement specification is written as “Omnipaque 70,” vendors often substitute by matching iodine concentration (mg I/mL) and osmolarity, not by matching the brand name alone.
- Substitution risk rises when “70” is ambiguous and buyers write without an iodine concentration or NDC equivalent.
Which distributors can be used to source Omnipaque 70?
Answer: The typical sourcing path is via authorized wholesalers/distributors handling GE HealthCare branded contrast media.
Where distributors sit in the chain
- Manufacturer: GE HealthCare.
- Wholesaler/distributor: supplies hospitals via GPO and direct purchasing.
- End user: hospital pharmacies and imaging centers.
What Orange Book or regulatory listings determine supplier eligibility?
Answer: Supplier eligibility in the US is determined by the specific approved NDA/ANDA and the corresponding product identity (strength, dosage form, and route).
Why “Omnipaque 70” cannot be resolved without a strength identifier
The US FDA “Orange Book” lists products under specific NDA/strength combinations (e.g., Omnipaque 240/300/350 in typical US product naming). A “70” strength label does not map uniquely to those FDA listing conventions from the information given.
Key Takeaways
- GE HealthCare is the brand holder/manufacturer source for Omnipaque products in the US through authorized distribution.
- A reliable supplier map for “OMNIPAQUE 70” requires an unambiguous strength and market mapping (iodine concentration and the regulatory product identity).
- Alternative iohexol sources exist, but substitution and competitive supplier lists are strength- and jurisdiction-dependent.
FAQs
- What companies sell iohexol contrast media that can substitute for Omnipaque by iodine concentration?
- Which wholesalers typically distribute GE HealthCare Omnipaque to hospitals and imaging centers?
- Does the FDA Orange Book list “Omnipaque 70” as a distinct US product strength?
- Are there differences in packaging or concentration that affect substitution of “Omnipaque 70” equivalents?
- How do hospital procurement specs determine whether an alternative iohexol is interchangeable with Omnipaque?
References (APA)
- FDA. (n.d.). Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. U.S. Food and Drug Administration.
- GE HealthCare. (n.d.). Omnipaque product information and prescribing information. GE HealthCare.
